# A Study to Investigate a Transdermal Continuous Glucose Monitoring System in Diabetic Patients for a Period of 28 Days

> **NCT06868043** · NA · TERMINATED · sponsor: **EyeSense GmbH** · enrollment: 10 (actual)

## Conditions studied

- Diabetes (DM)

## Interventions

- **DEVICE:** FiberSense System

## Key facts

- **NCT ID:** NCT06868043
- **Lead sponsor:** EyeSense GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2012-07
- **Primary completion:** 2012-10
- **Final completion:** 2014-06
- **Target enrollment:** 10 (ACTUAL)
- **Why stopped:** One cohort succesfully completed; further cohorts not needed, no safety issue.
- **Last updated:** 2025-03-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06868043

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06868043, "A Study to Investigate a Transdermal Continuous Glucose Monitoring System in Diabetic Patients for a Period of 28 Days". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT06868043. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*